查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363271

血漿蛋白治療市場規模、佔有率和趨勢分析報告：按產品、按用途、按地區和細分趨勢，2023-2030

Plasma Protein Therapeutics Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Plasma-derived Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 86 Pages | 商品交期: 2-10個工作天內

價格

血漿蛋白治療市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，血漿蛋白治療藥物的全球市場規模預計將達到451億美元，2023年至2030年的年複合成長率為6.1%。

這一成長的推動因素包括出血性疾病和其他罕見疾病的高患病、研發投資的增加以及血漿衍生產品在神經病學和其他治療適應症中的使用增加。

血漿衍生蛋白主要用作治療慢性罕見疾病的替代療法。依賴這些藥物的患者一生中需要定期注射或靜脈輸液。儘管有超過 250 種血漿衍生產品，但主要企業通常依賴免疫球蛋白 (IG)、白蛋白和凝血因子 VIII 來實現銷售和盈利。

在過去的年度中，血漿蛋白治療市場經歷了顯著的成長，其中免疫球蛋白佔據了主要的市場佔有率。對血漿衍生產品的需求是由疾病發病率上升、老年人口不斷增加以及新興市場獲得藥物的機會增加所推動的。新的血漿衍生治療方法的核准預計將進一步推動需求。中國和巴西等新興市場為全球市場巨頭提供了新的投資途徑。

血漿蛋白治療市場報告亮點

  • 由於原發性免疫力缺乏的流行、新適應症的使用以及易於給藥，因此對免疫球蛋白的需求預計將繼續增加。
  • 在凝血因子 VIII 市場中，非血漿重組療法可能會與血漿衍生產品競爭。
  • 原發性免疫力缺乏領域在 2022 年佔據了最大的市場佔有率，達到 26.5%，預計在預測期內將以 6.2% 的年複合成長率大幅成長。
  • 由於醫療保健支出增加、患者數量眾多、患病患者與接受治療的患者比例提高、藥品生產成本低廉，預計亞太地區在 2022 年將佔據最大市場佔有率，達到 35.7%。由於診斷技術的改進，預測期內年複合成長率最快為 8.6%。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 血漿蛋白治療市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 血漿蛋白治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 血漿蛋白治療藥物市場：產品估算與趨勢分析

  • 血漿蛋白治療市場：重點
  • 血漿蛋白治療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 白蛋白
  • 免疫球蛋白
  • 血漿衍生因子 VIII
  • 其他

第5章 血漿蛋白治療藥物市場：用途估算與趨勢分析

  • 血漿蛋白治療市場：重點
  • 血漿蛋白治療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 血友病
  • 原發性免疫力缺乏症 (PID)
  • 特發性血小板減少紫斑症（ITP）
  • 其他

第6章 血漿蛋白治療市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的血漿蛋白治療市場：重點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • CSL
    • Grifols, SA
    • Takeda
    • Octapharma AG
    • Biotest AG
    • Kedrion SpA
Product Code: GVR-2-68038-664-6

Plasma Protein Therapeutics Market Growth & Trends:

The global plasma protein therapeutics market size is expected to reach USD 45.1 billion by 2030, registering a CAGR of 6.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The growth can be attributed to high prevalence of bleeding and other rare disorders, rising investment in R&D, and increasing use of plasma-derived products in neurology and other therapeutic indications.

Plasma-derived proteins are primarily used as replacement therapies to treat chronic, rare diseases. Patients that rely on these medications require regular injections or infusions throughout their lives. While there are more than 250 products derived from plasma, key players generally rely on Immunoglobulin (IG), albumin, and factor VIII to drive sales and profitability.

Over the past decade, the plasma protein therapeutics market has grown lucratively with immunoglobulin capturing the major market share. Demand for plasma derived-products is driven by rising disease prevalence, geriatric population, and improved access to drugs in emerging markets. Approvals of new plasma-derived therapies are anticipated to further fuel the demand. Developing countries such as China and Brazil offer new investment avenues to the global market giants.

Plasma Protein Therapeutics Market Report Highlights:

  • Demand for immunoglobulin is expected to continue rising owing to prevalence of primary immunodeficiencies, usage in new indications, and ease of administration
  • Non-plasma based recombinant therapies are likely to compete with plasma-derived products in the factor VIII market
  • The primary immunodeficiency diseases segment captured the largest market share of 26.5% in 2022 and is expected to exhibit substantial growth with a CAGR of 6.2% through the forecast period
  • Asia Pacific accounted for the largest market share of 35.7% in 2022 and is expected to exhibit the fastest CAGR of 8.6% over the forecast period fueled by increasing healthcare expenditure, presence of a large number of patients. improved ratio of patients suffering from disease and patients receiving treatment, low-cost production of drugs, and improvement in diagnostic technology.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Plasma Protein Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Plasma Protein Therapeutics market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Plasma Protein Therapeutics market: Product Estimates & Trend Analysis

  • 4.1. Plasma Protein Therapeutics market: Key Takeaways
  • 4.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Albumin
    • 4.3.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Immunoglobulin
    • 4.4.1. Immunoglobulin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Plasma-derived Factor VIII
    • 4.5.1. Plasma-derived factor VIII market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Plasma Protein Therapeutics market: Application Estimates & Trend Analysis

  • 5.1. Plasma Protein Therapeutics market: Key Takeaways
  • 5.2. Plasma Protein Therapeutics market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hemophilia
    • 5.3.1. Hemophilia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Primary Immunodeficiency Disorder (PID)
    • 5.4.1. Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Idiopathic Thrombocytopenic Purpura (ITP)
    • 5.5.1. Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Plasma Protein Therapeutics market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Plasma Protein Therapeutics market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. CSL
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Grifols, S.A.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Takeda
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Octapharma AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Biotest AG
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Kedrion S.p.A
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 16 France plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 17 France plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 22 Denmark plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Sweden plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 33 China plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 34 China plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 35 India plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 36 India plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa plasma protein therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait plasma protein therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait plasma protein therapeutics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Plasma protein therapeutics: Market outlook
  • Fig. 9 Plasma protein therapeutics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Plasma protein therapeutics market driver impact
  • Fig. 15 Plasma protein therapeutics market restraint impact
  • Fig. 16 Plasma protein therapeutics market strategic initiatives analysis
  • Fig. 17 Plasma protein therapeutics market: Product movement analysis
  • Fig. 18 Plasma protein therapeutics market: Product outlook and key takeaways
  • Fig. 19 Albumin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunoglobulin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Factor VIII market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Plasma protein therapeutics market: Application movement analysis
  • Fig. 23 Plasma protein therapeutics market: Application outlook and key takeaways
  • Fig. 24 Hemophilia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Primary immunodeficiency disorder (PIDD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Idiopathic thrombocytopenic purpura (ITP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Global plasma protein therapeutics market: Regional movement analysis
  • Fig. 29 Global plasma protein therapeutics market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)